Related Experiment Video
Updated: Aug 10, 2026

Electrochemotherapy of Tumours
Published on: December 15, 2008
Alternating current electrical stimulation enhanced chemotherapy: a novel strategy to bypass multidrug resistance in
Damir Janigro1, Catalin Perju, Vincent Fazio
1Division of Cerebrovascular Research, Cleveland Clinic Lerner College of Medicine, Cleveland, OH 44106, USA. janigrd@ccf.org
Background:
Tumor burden can be pharmacologically controlled by inhibiting cell division and by direct, specific toxicity to the cancerous tissue. Unfortunately, tumors often develop intrinsic pharmacoresistance mediated by specialized drug extrusion mechanisms such as P-glycoprotein. As a consequence, malignant cells may become insensitive to various anti-cancer drugs. Recent studies have shown that low intensity very low frequency electrical stimulation by alternating current (AC) reduces the proliferation of different tumor cell lines by a mechanism affecting potassium channels while at intermediate frequencies interfere with cytoskeletal mechanisms of cell division. The aim of the present study is to test the hypothesis that permeability of several MDR1 over-expressing tumor cell lines to the chemotherapic agent doxorubicin is enhanced by low frequency, low intensity AC stimulation.
Methods:
We grew human and rodent cells (C6, HT-1080, H-1299, SKOV-3 and PC-3) which over-expressed MDR1 in 24-well Petri dishes equipped with an array of stainless steel electrodes connected to a computer via a programmable I/O board. We used a dedicated program to generate and monitor the electrical stimulation protocol. Parallel cultures were exposed for 3 hours to increasing concentrations (1, 2, 4, and 8 microM) of doxorubicin following stimulation to 50 Hz AC (7.5 microA) or MDR1 inhibitor XR9576. Cell viability was assessed by determination of adenylate kinase (AK) release. The relationship between MDR1 expression and the intracellular accumulation of doxorubicin as well as the cellular distribution of MDR1 was investigated by computerized image analysis immunohistochemistry and Western blot techniques.
Results:
By the use of a variety of tumor cell lines, we show that low frequency, low intensity AC stimulation enhances chemotherapeutic efficacy. This effect was due to an altered expression of intrinsic cellular drug resistance mechanisms. Immunohistochemical, Western blot and fluorescence analysis revealed that AC not only decreases MDR1 expression but also changes its cellular distribution from the plasma membrane to the cytosol. These effects synergistically contributed to the loss of drug extrusion ability and increased chemo-sensitivity.
Conclusion:
In the present study, we demonstrate that low frequency, low intensity alternating current electrical stimulation drastically enhances chemotherapeutic efficacy in MDR1 drug resistant malignant tumors. This effect is due to an altered expression of intrinsic cellular drug resistance mechanisms. Our data strongly support a potential clinical application of electrical stimulation to enhance the efficacy of currently available chemotherapeutic protocols.
Insights
Low frequency alternating current (AC) electrical stimulation enhances chemotherapy effectiveness in drug-resistant tumors by reducing P-glycoprotein expression. This approach increases chemo-sensitivity, offering a promising strategy for cancer treatment.
Area of Science:
- Oncology
- Biophysics
- Biochemistry
Background:
- Malignant tumors often develop resistance to chemotherapy through drug extrusion mechanisms like P-glycoprotein.
- This resistance limits the effectiveness of anti-cancer drugs, necessitating novel therapeutic strategies.
- Alternating current (AC) electrical stimulation has shown potential in affecting tumor cell proliferation and division.
Purpose of the Study:
- To investigate if low frequency, low intensity AC stimulation can enhance the permeability of multidrug resistance gene 1 (MDR1) over-expressing tumor cells to doxorubicin.
- To explore the underlying mechanisms by which AC stimulation affects drug resistance in cancer cells.
Main Methods:
- Human and rodent tumor cell lines over-expressing MDR1 were cultured and exposed to AC stimulation.
- Cells were subsequently treated with doxorubicin, and cell viability was assessed.
- MDR1 expression, intracellular doxorubicin accumulation, and MDR1 cellular distribution were analyzed using immunohistochemistry, Western blot, and computerized image analysis.
Main Results:
- Low frequency, low intensity AC stimulation was found to enhance chemotherapeutic efficacy across various tumor cell lines.
- AC stimulation reduced MDR1 expression and altered its cellular distribution from the plasma membrane to the cytosol.
- These changes led to decreased drug extrusion ability and increased chemo-sensitivity.
Conclusions:
- Low frequency, low intensity AC electrical stimulation significantly enhances chemotherapeutic efficacy in MDR1 drug-resistant malignant tumors.
- The observed enhancement is attributed to altered expression and cellular distribution of intrinsic drug resistance mechanisms.
- These findings suggest a potential clinical application of electrical stimulation to improve current chemotherapy protocols.
Related Concept Videos
Treatment Resistant Cancers
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

